External Email - Use Caution        

Hello Alberto, 

Thanks for answering ! I was asking for clarifications about the license because we are not a profit organization. We provide open-source software and use Freesurfer in it. I was then wondering if it was okay to distribute (freely) Freesurfer alongside our software clinica inside a docker container, just like fmriprep does for instance.

Best,
Alice

De : Alberto Benelli <alberto.benelli@unifi.it>
Date : jeudi, 15 octobre 2026 à 12:00
À : Freesurfer support list <freesurfer@nmr.mgh.harvard.edu>
Objet : [Freesurfer] Re: [RE] Publishing a docker container with Freesurfer inside

Vous n’obtenez pas souvent d’e-mail à partir de alberto.benelli@unifi.it. Pourquoi c’est important
        External Email - Use Caution        
Hi,

I’m not getting how may I help you with 

Alberto

On Thu, 15 Oct 2026 at 11:57, JOUBERT Alice <alice.joubert@icm-institute.org> wrote:
        External Email - Use Caution        
Hello,

I am very sorry for asking again, if you answered it seems it did not reach me and I would like to do things properly : 

Thanks for developing FreeSurfer ! My lab uses it regularly, especially along our own software Clinica. I had a question regarding your license limitations. We plan on making Docker containers that would include both Clinica and external software such as FreeSurfer. Would you be okay with it if we made it (ie FreeSurfer binaries) openly available ? It would be free/open-source and users would still need to mount their own FreeSurfer License to the container.


Best,

Alice Joubert,
Research Engineer at ARAMIS
Paris Brain Institute




_______________________________________________
Freesurfer mailing list -- freesurfer@nmr.mgh.harvard.edu
To unsubscribe send an email to freesurfer-leave@nmr.mgh.harvard.edu
https://mail.nmr.mgh.harvard.edu/mailman3/lists/freesurfer@nmr.mgh.harvard.edu/
The information in this e-mail is intended only for the person to whom it is addressed.  If you believe this e-mail was sent to you in error and the e-mail contains patient information, please contact the Mass General Brigham Compliance HelpLine at https://www.massgeneralbrigham.org/complianceline <https://www.massgeneralbrigham.org/complianceline> .
Please note that this e-mail is not secure (encrypted).  If you do not wish to continue communication over unencrypted e-mail, please notify the sender of this message immediately.  Continuing to send or respond to e-mail after receiving this message means you understand and accept this risk and wish to continue to communicate over unencrypted e-mail.